Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Type 1 Diabetes and Autism

Is there a link?

  1. Sloane J. Freeman, MD1,
  2. Wendy Roberts, MD2 and
  3. Denis Daneman, MD1
  1. 1Division of Endocrinology, The Hospital for Sick Children and University of Toronto, Toronto, Canada
  2. 2Child Development Centre, The Hospital for Sick Children and University of Toronto, Toronto, Canada
  1. Address correspondence and reprint requests to Dr. Denis Daneman, Division of Endocrinology, The Hospital for Sick Children, Toronto, Ontario. E-mail: denis.daneman{at}sickkids.ca
Diabetes Care 2005 Apr; 28(4): 925-926. https://doi.org/10.2337/diacare.28.4.925
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Is there a link?

The prevalence of diabetes in children and youth <18 years of age is ∼1 in 400–500 (1). The prevalence of diabetes for those aged <19 years from 1995–2000 in Ontario was 1.87 per 1,000 (2). Type 1 diabetes is recognized as a T-cell–mediated autoimmune process with a strong genetic contribution (3,4).

In 2003, the prevalence of autism spectrum disorder was reported in one study as 3.4 per 1,000 children (5) and in another as 6.7 per 1,000 children (4 per 1,000 children with autism) aged 3–10 years (6) in the U.S. Like type 1 diabetes, both immune-mediated and genetic factors have been implicated in the development of autism (7,8). Based on recent clinical experiences and on the putative autoimmune etiology of these two conditions, we hypothesized that there would be an increased prevalence of autism spectrum disorder in a population of children with type 1 diabetes.

To investigate this hypothesis, a retrospective chart review of nearly 1,000 children with type 1 diabetes followed at the Diabetes Clinic at The Hospital for Sick Children was performed to identify children with autism spectrum disorder.

RESEARCH DESIGN AND METHODS

Children with both type 1 diabetes and autism spectrum disorder were identified (n = 9) by a retrospective chart review of all children with diabetes (n = 984 in 2002) attending the Diabetes Clinic at The Hospital for Sick Children. With respect to autism spectrum disorder, the data selected included age at diagnosis, method of diagnosis, and family history of autism spectrum disorder or learning disorders. For those identified, the diagnosis of autism spectrum disorder had been made previously by either a psychiatrist or developmental pediatrician.

The 95% CI was calculated for the prevalence of autism spectrum disorder in our population of children with type 1 diabetes.

RESULTS

Of 984 individual children with diabetes seen in our Diabetes Clinic in 2002, 9 were identified as having autism spectrum disorder (0.9% [95% CI 0.3–1.5]). There were seven male and two female subjects.

The median age at diagnosis of autism spectrum disorder was 4.8 years (range 3.3–6.8), while that for type 1 diabetes was 8.2 years (range 0.8–13.5). In five children, the diagnosis of autism spectrum disorder was made following evaluation by a staff psychiatrist or developmental pediatrician at The Hospital for Sick Children. The diagnosis was made in two children following evaluation by developmental pediatricians in the community. Three children were also identified as having a family history of some form of developmental disorder.

CONCLUSIONS

Our data suggest that the prevalence of autism spectrum disorder in children with type 1 diabetes attending the Diabetes Clinic at The Hospital for Sick Children, Toronto, may be greater than that in the general population (0.9% [95% CI 0.3–1.5] vs. 0.34–0.67) (4,6). Certain factors may account for this finding, including a common autoimmune pathogenesis. In 1971, Money et al. (9) reported a possible association between autism and a family history of autoimmune disease in a case report. In addition, Denney et al. (10) described a lower percentage of helper-inducer cells and a decreased helper–to–suppressor cell ratio in children with autism, as well as a lower percentage of lymphocytes expressing bound interleukin-2 receptors, following mitogenic stimulation compared with control subjects. These findings were inversely related to the severity of autistic symptoms. Gupta et al. (11) reported findings that suggest that an imbalance of Th1- and Th2-like cytokines may be important in the pathogenesis of autism. Similarly, Plioplys et al. (12) reported on 11 of 17 patients with autism who had findings suggestive of “incomplete activation” of T-cells, a finding also seen in autoimmune diseases. Comi et al. (13) reported an increased incidence of autoimmune diseases in mothers of patients with autism compared with control mothers. A recently reported link between autism and autoimmune thyroid disorder increases the likelihood of finding some shared autoimmune etiologic process (14). Furthermore, autoantibodies implicated in autoimmune thyroid disorders are found with an increased prevalence in patients with type 1 diabetes (15–17).

A possible referral bias, the small sample size, and the absence of specific autism surveillance measures used for all children attending the Diabetes Clinic limit the generalizability of these findings. However, while our findings must be viewed as preliminary, our experience suggests that a large multicenter study involving a large sample size is required to confirm or refute an association between these two conditions.

Our report of an increased prevalence of autism spectrum disorder in a population of children with type 1 diabetes emphasizes the need to recognize a potential association between these two diseases allowing for better overall patient identification and referral for appropriate care. Confirmation of an association between type 1 diabetes and autism spectrum disorder may provide important insights into the pathogenesis of both conditions.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted December 26, 2004.
    • Received September 8, 2004.
  • DIABETES CARE

References

  1. ↵
    Centers for Disease Control and Prevention/National Center for Chronic Disease Prevention and Health Promotion: National diabetes fact sheet [article online], 2000. Available from http://www.cdc.gov/diabetes/pubs/facts98.htm. Accessed 3 March 2004
  2. ↵
    To T, Curtis JR, Daneman D: Diabetes in children. In Diabetes in Ontario. Hux J, Booth G, Slaughter P, Laupacis A, Eds. Toronto, ICES, 2003, p. 219–230
  3. ↵
    Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516–542, 1994
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Devendra D, Liu E, Eisenbarth GS: Type 1 diabetes: recent developments. BMJ 328:750–754, 2004
    OpenUrlFREE Full Text
  5. ↵
    Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C: Prevalence of autism in a US metropolitan area. JAMA 289:49–55, 2003
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P: Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108:1155–1161, 2001
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Farber JM: Autism and other communication disorders. In Developmental Disabilities in Infancy and Childhood. 2nd ed. Capute AJ, Accardo PJ, Eds. Baltimore, MD, Brookes, 1996, p. 347–364
  8. ↵
    Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE: Genetics of autism: overview and new directions. J Autism Dev Disord 28:351–368, 1998
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Money J, Bobrow NA, Clarke FC: Autism and autoimmune disease: a family study. J Autism Child Schizophr 1:146–160, 1971
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Denney DR, Frei BW, Gaffney GR: Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 26:87–97, 1996
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Gupta S, Aggarwal S, Rashanravan B, Lee T: Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85:106–109, 1998
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Plioplys AV, Greaves A, Kazemi K, Silverman E: Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29:12–16, 1994
    OpenUrlPubMedWeb of Science
  13. ↵
    Comi AM, Zimmerman AW, Frye VH, Law A, Peeden JN: Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neuro 14:388–394, 1999
  14. ↵
    Malloy C, Morrow A, Meinzen-Derr J, Lord C: Familial autoimmunity as a risk factor for regression in children with autism spectrum disorder: a CPEA study (Abstract). Sacramento, CA, International Meeting for Autism Research, 2004
  15. ↵
    Mennon PS, Vaidyanathan B, Kaur M: Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14:279–286, 2001
    OpenUrlPubMed
  16. Park YS, Kim TW, Kim WB, Cho BY: Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J Intern Med 15:202–210, 2000
    OpenUrlPubMed
  17. ↵
    Prazny M, Skrha J, Limanova Z, Hilgertova J: The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus. Sb Lek 100:205–211, 1999
    OpenUrlPubMed
PreviousNext
Back to top
Diabetes Care: 28 (4)

In this Issue

April 2005, 28(4)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Type 1 Diabetes and Autism
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Type 1 Diabetes and Autism
Sloane J. Freeman, Wendy Roberts, Denis Daneman
Diabetes Care Apr 2005, 28 (4) 925-926; DOI: 10.2337/diacare.28.4.925

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Type 1 Diabetes and Autism
Sloane J. Freeman, Wendy Roberts, Denis Daneman
Diabetes Care Apr 2005, 28 (4) 925-926; DOI: 10.2337/diacare.28.4.925
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Elevated Cystatin C Concentration and Progression to Pre-Diabetes
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.